SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-22-000137
Filing Date
2022-11-01
Accepted
2022-11-01 09:03:18
Documents
13
Period of Report
2022-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20221101.htm   iXBRL 8-K 47030
2 EX-99.1 mygn-xq322earningsreleasex.htm EX-99.1 504663
  Complete submission text file 0000899923-22-000137.txt   725159

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20221101.xsd EX-101.SCH 1884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20221101_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20221101_pre.xml EX-101.PRE 12496
7 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20221101_htm.xml XML 11754
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 221348665
SIC: 2835 In Vitro & In Vivo Diagnostic Substances